Tag Archives: patients

FDA agrees to fast-track review of Amarin’s prescription strength fish oil pill for heart patients

Vascepa Source: Amarin Amarin shares surged 15% in early afternoon trading Wednesday after the biopharmaceutical company said the Food and Drug Administration agreed to an expedited review of its prescription-strength fish oil pill for patients at risk of heart attack or strokes. The FDA will grant priority review for Amarin’s heart drug derived from fish… Read More »

FDA Approves Zolgensma (onasemnogene abeparvovec-xioi) Gene Therapy to Treat Pediatric Patients with Spinal Muscular Atrophy

FDA Approves Zolgensma (onasemnogene abeparvovec-xioi) Gene Therapy to Treat Pediatric Patients with Spinal Muscular Atrophy Print this page May 24, 2019 — The U.S. Food and Drug Administration today approved Zolgensma (onasemnogene abeparvovec-xioi), the first gene therapy approved to treat children less than two years of age with spinal muscular atrophy (SMA), the most severe… Read More »

Low mobility predicts hospital readmission in older heart attack patients

Under the threat of financial penalty, hospitals are always on the lookout for ways to reduce their 30-day readmissions. For heart attack patients in particular,conducting a simple mobility test might be the best means of forecasting which patients are likely to return. Close to 20 percent of elderly adults who have suffered a heart attack… Read More »